Jason Guichard is a Cardiology physician affiliated with Prisma Health. OpenAlex indexes 59 publications with 814 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1005 Grove Rd
Greenville, SC 296054630
Telephone
864-455-6900Provider last certified this registry record 8 Jun 2021.
Clinical trials
- VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
Sponsor: Prisma Health-Upstate
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CVRx, Inc.Program year20259 payments
- ENDOTRONIX, INC.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.8%Aldosterone antagonist (MRA)20.1%Spironolactone90%Eplerenone10%Part D≥166 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)14.9%Entresto100%Part D≥95 patients+ 11 more classes in this area
Metabolism & gastrointestinal
13.4%SGLT2 inhibitor12.4%Jardiance70%Farxiga30%Part D≥81 patientsPotassium supplement0.9%Potassium Chloride100%Part D<11 patientsBlood & clotting
5.5%Factor Xa inhibitor3.5%Eliquis72%Xarelto28%Part D<11 patientsProstacycline Vasodilator2%Tyvaso Dpi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Two-Year Results of PROACTIVE-HF Trial Stratified by Left Ventricular Ejection Fraction
Journal of Cardiac Failure
2026 - Improved Efficiency and Data Presentation Using an Epic SmartForm
The Journal of Heart and Lung Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gopi Dandamudi, MD
Prisma Health
Ezequiel Gleichgerrcht, MD, PhD
Prisma Health
Anthony Gregg, MD
Prisma Health
Fredy Revilla, MD
Prisma Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”